drugset / Trial / NCT04331743
A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC
NaSingle-groupOpen-labelTreatment
Summary
This is a dose escalation study based on 3+3 design with the aim to establish MTD and provide RP2D. PLM60 is to administered by multi-cycle intravenous infusion.
Timeline
- Start
- 2021-06-05
- Primary completion
- 2023-05-15
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitoxantrone | Small molecule | — | Intravenous |